Compare NIO Inc. (NIO) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NIO Inc. vs Teladoc Health Inc — how do they compare? NIO Inc. trades at $3.58 (market cap $8.62B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: NIO Inc. is far larger — about 8.5× Teladoc Health Inc's market cap, and Teladoc Health Inc is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NIO Inc. for 81 Days and Teladoc Health Inc for 39 Days on average.
| NIO | TDOC | |
|---|---|---|
Market Cap | $8.62B | $1.01B |
Volume | 39,648,517 | 4,668,477 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.46 | $9.72 |
52-Week Low | $3.37 | $4.47 |
Typical Hold Time | 81 Days | 39 Days |
Enterprise Value | $6.52B | $1.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NIO trades at $3.41, down 3.67% today and near its 52-week low, reflecting bearish technical signals. The company reported Q3 2026 deliveries up 25.4% but continues to post net losses, with a -4.17% net income margin in 2026. Recent news highlights a strategic battery-swap partnership with Geely, valued at $2.38 billion for NIO Power, aiming to expand charging infrastructure amid a competitive EV price war in China.
The outlook remains challenging due to persistent losses and high debt, though revenue growth and analyst consensus suggest long-term potential. Risks include intense competition, margin pressure, and macroeconomic headwinds. With a $6.23 average price target, analysts see 83% upside, but investors must weigh profitability improvements against ongoing cash burn.
Teladoc Health (TDOC) trades at $5.54, down 0.36% on the day, as the stock faces bearish technical momentum despite recent earnings beats. The company maintains strong revenue around $2.5B annually but continues to report net losses, with a -7.13% net income margin in 2026. Analyst sentiment is mixed with 35.7% buy ratings but a consensus price target of $8.83 suggesting 59% upside potential. Recent CFO appointment and legal officer transitions signal management changes amid ongoing operational challenges.
TDOC presents a high-risk opportunity with significant valuation discount (P/S 0.4x) but faces persistent profitability challenges. The integrated care business shows promise with improving margins, while BetterHelp weakness and negative cash flow in 2025 raise concerns. Upside depends on successful execution of turnaround strategy and achieving sustainable profitability in the competitive telehealth market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
